Skip to main content

Table S1 from Peripheral Blood IFN Responses to Toll-Like Receptor 1/2 Signaling Associate with Longer Survival in Men with Metastatic Prostate Cancer Treated with Sipuleucel-T

Publication ,  Other
Brown, MC; D’Anniballe, VM; Boczkowski, D; Kandadi, H; Sheikh, N; Kornahrens, W; Heath, EI; Thakur, A; Chen, W; Lum, L; Cackowski, FC ...
April 3, 2025

<p>Clinical cohort characteristics</p>

Duke Scholars

DOI

Publication Date

April 3, 2025
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Brown, M. C., D’Anniballe, V. M., Boczkowski, D., Kandadi, H., Sheikh, N., Kornahrens, W., … Nair, S. K. (2025). Table S1 from Peripheral Blood IFN Responses to Toll-Like Receptor 1/2 Signaling Associate with Longer Survival in Men with Metastatic Prostate Cancer Treated with Sipuleucel-T. https://doi.org/10.1158/2767-9764.28727833
Brown, Michael C., Vincent M. D’Anniballe, David Boczkowski, Harini Kandadi, Nadeem Sheikh, William Kornahrens, Elisabeth I. Heath, et al. “Table S1 from Peripheral Blood IFN Responses to Toll-Like Receptor 1/2 Signaling Associate with Longer Survival in Men with Metastatic Prostate Cancer Treated with Sipuleucel-T,” April 3, 2025. https://doi.org/10.1158/2767-9764.28727833.
Brown MC, D’Anniballe VM, Boczkowski D, Kandadi H, Sheikh N, Kornahrens W, Heath EI, Thakur A, Chen W, Lum L, Cackowski FC, Boerner J, Gunn MD, Armstrong AJ, Nair SK. Table S1 from Peripheral Blood IFN Responses to Toll-Like Receptor 1/2 Signaling Associate with Longer Survival in Men with Metastatic Prostate Cancer Treated with Sipuleucel-T. 2025.

DOI

Publication Date

April 3, 2025